GENETHON

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 19148
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 16239
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 693
 
 
 
C07K PEPTIDES 3133
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 3203
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 247
 
 
 
A61N ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 1106
 
 
 
C04B LIME; MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS 167
 
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 198
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0066,283 WIDESPREAD GENE DELIVERY TO MOTOR NEURONS USING PERIPHERAL INJECTION OF AAV VECTORSSep 22, 17Mar 08, 18[C12N]
2017/0071,972 METHOD OF TREATING PERIPHERAL NEUROPATHIES AND MOTOR NEURON DISEASESApr 20, 15Mar 16, 17[A61K]
2015/0252,335 BACULOVIRUS-BASED PRODUCTION OF BIOPHARMACEUTICALS FREE OF CONTAMINATING BACULOVIRAL VIRIONSMar 27, 15Sep 10, 15[C12N]
2014/0315,294 SCALABLE LENTIVIRAL VECTOR PRODUCTION SYSTEM COMPATIBLE WITH INDUSTRIAL PHARMACEUTICAL APPLICATIONSNov 26, 12Oct 23, 14[C12N]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9895426 Systemic gene replacement therapy for treatment of X-linked myotubular myopathy (XLMTM)Dec 20, 16Feb 20, 18[A61K, C07H, C12P, C12N]
9862934 Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virionsMar 27, 15Jan 09, 18[C12N]
9839677 Systemic gene replacement therapy for treatment of X-linked myotubular myopathy (XLMTM)Jul 26, 16Dec 12, 17[A61K, C07H, C12P, C12N]
9777272 Methods for the treatment of Leber congenital amaurosisSep 16, 16Oct 03, 17[A61K, C07H, C12N]
9546112 Methods of increasing efficiency of vector penetration of target tissueMar 22, 11Jan 17, 17[A61K, C04B, C12N, A61N, C07K]
9526742 Use of epigenome-modifying compounds for the treatment of genetic muscular diseases linked to a protein-conformational disorderJul 16, 13Dec 27, 16[A61K, G01N]
9415120 Systemic gene replacement therapy for treatment of X-linked MyoTubular Myopathy (XLMTM)Jan 13, 15Aug 16, 16[A61K, C07H, C12P, C12N]
9114161 Widespread gene delivery to the retina using systemic administration of AAV vectorsJul 30, 10Aug 25, 15[A61K, C12N, A61P]
8993317 Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virionsAug 05, 10Mar 31, 15[C12N, C07K]
8957044 Systemic gene replacement therapy for treatment of X-linked myotubular myopathy (XLMTM)Feb 28, 14Feb 17, 15[A61K, C07H, C12P, C12N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0247,196 IN VITRO GENETIC DIAGNOSTIC OF INHERITED NEUROMUSCULAR DISORDERSAbandonedSep 06, 13Sep 03, 15[C12Q]
2014/0342,937 METHODS FOR DIAGNOSIS AND THERAPEUTIC FOLLOW-UP OF MUSCULAR DYSTROPHIESAbandonedDec 14, 12Nov 20, 14[C12Q]
2013/0171,172 CALPAIN-3 INHIBITORS FOR TREATING MUSCULAR DYSTROPHIES AND CARDIOMYOPATHIESAbandonedJun 30, 11Jul 04, 13[A61K]
2013/0072,541 ADENO-ASSOCIATED VIRAL VECTOR FOR EXON SKIPPING IN A GENE ENCODING A DISPENSIBLE-DOMAIN PROTEINAbandonedApr 27, 12Mar 21, 13[A61K, C12N, A61P]
2012/0077,860 Adeno-Associated Viral Vector for Exon Skipping in a Gene Encoding a Dispensable Domain ProteinAbandonedAug 02, 05Mar 29, 12[A61K, C12N, A01K]
2010/0266,551 ADENO-ASSOCIATED VIRAL VECTORS FOR THE EXPRESSION OF DYSFERLINAbandonedJul 25, 08Oct 21, 10[A61K, C12P, C12N, A61P]
2009/0220,468 Specific CD4+CD25+ Regulatory T Cells for Haematopoietic Cell Transplantation and Immune ToleranceAbandonedMar 09, 07Sep 03, 09[A61K]
2006/0257,380 Use of sirnas for gene silencing in antigen presenting cellsAbandonedSep 19, 02Nov 16, 06[A61K, C12N]
2005/0177,880 Nucleic acid isolated from the 5' nontranslated region (5'NTR) end of the human FGF-1 gene having IRES activityAbandonedDec 22, 04Aug 11, 05[C07H, C12Q, C12N, A01K]
6846623 LGMD gene coding for a calcium dependent proteaseExpiredJul 02, 97Jan 25, 05[C07H, C12Q, C12P]
2004/0180,395 Method for detecting calpain3 activity in a biological sample and peptides for implementing said methodAbandonedMay 27, 03Sep 16, 04[C12Q, C07K]
2004/0096,972 Chimeric plasmid comprising a replicative retroviral genome, and usesAbandonedOct 02, 03May 20, 04[C12N]
2004/0009,505 Uses of the GJB6 gene for treating certain types of alopecia including the Clouston's syndrome, and for screening compounds capable of being efficient in the treatment of alopecia genetic susceptibilityAbandonedMar 27, 03Jan 15, 04[C07H, A61K, C12Q, C12N, A01K]
2003/0100,116 Canine adenovirus vectors for the transfer of genes in targeted cellsAbandonedJun 07, 02May 29, 03[A61K, C07H, C12N]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.